Loading…

Attrition from HIV treatment after enrollment in a differentiated service delivery model: A cohort analysis of routine care in Zambia

Many sub-Saharan Africa countries are scaling up differentiated service delivery (DSD) models for HIV treatment to increase access and remove barriers to care. We assessed factors associated with attrition after DSD model enrollment in Zambia, focusing on patient-level characteristics. We conducted...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2023-03, Vol.18 (3), p.e0280748-e0280748
Main Authors: Jo, Youngji, Jamieson, Lise, Phiri, Bevis, Grimsrud, Anna, Mwansa, Muya, Shakwelele, Hilda, Haimbe, Prudence, Mukumbwa-Mwenechanya, Mpande, Mulenga, Priscilla Lumano, Nichols, Brooke E, Rosen, Sydney
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c693t-90510a094cae81c8f7c91f3525f4e385edfa6875cd4a92d74ccaec97136088103
cites cdi_FETCH-LOGICAL-c693t-90510a094cae81c8f7c91f3525f4e385edfa6875cd4a92d74ccaec97136088103
container_end_page e0280748
container_issue 3
container_start_page e0280748
container_title PloS one
container_volume 18
creator Jo, Youngji
Jamieson, Lise
Phiri, Bevis
Grimsrud, Anna
Mwansa, Muya
Shakwelele, Hilda
Haimbe, Prudence
Mukumbwa-Mwenechanya, Mpande
Mulenga, Priscilla Lumano
Nichols, Brooke E
Rosen, Sydney
description Many sub-Saharan Africa countries are scaling up differentiated service delivery (DSD) models for HIV treatment to increase access and remove barriers to care. We assessed factors associated with attrition after DSD model enrollment in Zambia, focusing on patient-level characteristics. We conducted a retrospective record review using electronic medical records (EMR) of adults (≥15 years) initiated on antiretroviral (ART) between 01 January 2018 and 30 November 2021. Attrition was defined as lost to follow-up (LTFU) or died by November 30, 2021. We categorized DSD models into eight groups: fast-track, adherence groups, community pick-up points, home ART delivery, extended facility hours, facility multi-month dispensing (MMD, 4-6-month ART dispensing), frequent refill care (facility 1-2 month dispensing), and conventional care (facility 3 month dispensing, reference group). We used Fine and Gray competing risk regression to assess patient-level factors associated with attrition, stratified by sex and rural/urban setting. Of 547,281 eligible patients, 68% (n = 372,409) enrolled in DSD models, most commonly facility MMD (n = 306,430, 82%), frequent refill care (n = 47,142, 13%), and fast track (n = 14,433, 4%), with
doi_str_mv 10.1371/journal.pone.0280748
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2786773965</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A741215632</galeid><doaj_id>oai_doaj_org_article_405ee3bdd0ff49aca71aaf03ae1748db</doaj_id><sourcerecordid>A741215632</sourcerecordid><originalsourceid>FETCH-LOGICAL-c693t-90510a094cae81c8f7c91f3525f4e385edfa6875cd4a92d74ccaec97136088103</originalsourceid><addsrcrecordid>eNqNk81uEzEQx1cIREvhDRBYQkJwSLDX--HlgqIKaKRKlfjogYs18Y4TR7vr1PZG5AF4b5xmW2VRD8gH2-Pf_Gc89iTJS0anjJfsw9r2roNmurEdTmkqaJmJR8kpq3g6KVLKHx-tT5Jn3q8pzbkoiqfJCS8qVuaFOE3-zEJwJhjbEe1sSy7m1yQ4hNBiFwjogI5g52zT3BpMR4DURmt0cWsgYE08uq1RSGpszBbdjrQ2Lj-SGVF2ZV1UiWnuvPHEauJsH0yHRIHDvdovaBcGnidPNDQeXwzzWfLzy-cf5xeTy6uv8_PZ5UQVFQ-TiuaMAq0yBSiYErpUFdM8T3OdIRc51hoKUeaqzqBK6zJTEVRVyXhBhWCUnyWvD7qbxno5VNDLtBRFWfKqyCMxPxC1hbXcONOC20kLRt4arFtKcMGoBmVGc0S-qGuqdVaBgpIBaMoBWXyKehG1Pg3R-kWLtYoVc9CMRMcnnVnJpd1KRinjQqRR4d2g4OxNjz7I1niFTQMd2v6QuGBpKrKIvvkHffh6A7WEeAPTaRsDq72onJUZS1le8H3Y6QNUHDW2RsX_pk20jxzejxwiE_B3WELvvZx___b_7NX1mH17xK4QmrDytun3_9WPwewAKme9d6jvq8yo3LfLXTXkvl3k0C7R7dXxC9073fUH_wtCZhGF</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2786773965</pqid></control><display><type>article</type><title>Attrition from HIV treatment after enrollment in a differentiated service delivery model: A cohort analysis of routine care in Zambia</title><source>Publicly Available Content Database</source><source>PubMed</source><source>Coronavirus Research Database</source><creator>Jo, Youngji ; Jamieson, Lise ; Phiri, Bevis ; Grimsrud, Anna ; Mwansa, Muya ; Shakwelele, Hilda ; Haimbe, Prudence ; Mukumbwa-Mwenechanya, Mpande ; Mulenga, Priscilla Lumano ; Nichols, Brooke E ; Rosen, Sydney</creator><contributor>Bartlett, Adam W.</contributor><creatorcontrib>Jo, Youngji ; Jamieson, Lise ; Phiri, Bevis ; Grimsrud, Anna ; Mwansa, Muya ; Shakwelele, Hilda ; Haimbe, Prudence ; Mukumbwa-Mwenechanya, Mpande ; Mulenga, Priscilla Lumano ; Nichols, Brooke E ; Rosen, Sydney ; Bartlett, Adam W.</creatorcontrib><description>Many sub-Saharan Africa countries are scaling up differentiated service delivery (DSD) models for HIV treatment to increase access and remove barriers to care. We assessed factors associated with attrition after DSD model enrollment in Zambia, focusing on patient-level characteristics. We conducted a retrospective record review using electronic medical records (EMR) of adults (≥15 years) initiated on antiretroviral (ART) between 01 January 2018 and 30 November 2021. Attrition was defined as lost to follow-up (LTFU) or died by November 30, 2021. We categorized DSD models into eight groups: fast-track, adherence groups, community pick-up points, home ART delivery, extended facility hours, facility multi-month dispensing (MMD, 4-6-month ART dispensing), frequent refill care (facility 1-2 month dispensing), and conventional care (facility 3 month dispensing, reference group). We used Fine and Gray competing risk regression to assess patient-level factors associated with attrition, stratified by sex and rural/urban setting. Of 547,281 eligible patients, 68% (n = 372,409) enrolled in DSD models, most commonly facility MMD (n = 306,430, 82%), frequent refill care (n = 47,142, 13%), and fast track (n = 14,433, 4%), with &lt;2% enrolled in the other DSD groups. Retention was higher in nearly all DSD models for all dispensing intervals, compared to the reference group, except fast track for the ≤2 month dispensing group. Retention benefits were greatest for patients in the extended clinic hours group and least for fast track dispensing. Although retention in HIV treatment differed by DSD type, dispensing interval, and patient characteristics, nearly all DSD models out-performed conventional care. Understanding the factors that influence the retention of patients in DSD models could provide an important step towards improving DSD implementation.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0280748</identifier><identifier>PMID: 36917568</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adult ; AIDS treatment ; Analysis ; Anti-HIV Agents - therapeutic use ; Anti-Retroviral Agents - therapeutic use ; Antiretroviral agents ; Antiretroviral drugs ; Antiretroviral therapy ; Antiviral agents ; Biology and Life Sciences ; Care and treatment ; Clinical outcomes ; Cohort analysis ; Cohort Studies ; Computer and Information Sciences ; Datasets ; Dispensing ; Dosage and administration ; Drug therapy ; Electronic health records ; Electronic medical records ; Enrollments ; Health risks ; HIV ; HIV (Viruses) ; HIV Infections - drug therapy ; HIV Infections - epidemiology ; HIV patients ; Human immunodeficiency virus ; Humans ; Medical records ; Medical research ; Medicine and Health Sciences ; Medicine, Experimental ; Modelling ; Patient satisfaction ; Patients ; People and Places ; Retention ; Retrospective Studies ; Sexually transmitted diseases ; STD ; Urban areas ; Urban environments ; Zambia - epidemiology</subject><ispartof>PloS one, 2023-03, Vol.18 (3), p.e0280748-e0280748</ispartof><rights>Copyright: © 2023 Jo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</rights><rights>COPYRIGHT 2023 Public Library of Science</rights><rights>2023 Jo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 Jo et al 2023 Jo et al</rights><rights>2023 Jo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c693t-90510a094cae81c8f7c91f3525f4e385edfa6875cd4a92d74ccaec97136088103</citedby><cites>FETCH-LOGICAL-c693t-90510a094cae81c8f7c91f3525f4e385edfa6875cd4a92d74ccaec97136088103</cites><orcidid>0000-0002-6560-2964 ; 0000-0002-1199-8377</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2786773965/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2786773965?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25751,27922,27923,37010,37011,38514,43893,44588,53789,53791,74182,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36917568$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Bartlett, Adam W.</contributor><creatorcontrib>Jo, Youngji</creatorcontrib><creatorcontrib>Jamieson, Lise</creatorcontrib><creatorcontrib>Phiri, Bevis</creatorcontrib><creatorcontrib>Grimsrud, Anna</creatorcontrib><creatorcontrib>Mwansa, Muya</creatorcontrib><creatorcontrib>Shakwelele, Hilda</creatorcontrib><creatorcontrib>Haimbe, Prudence</creatorcontrib><creatorcontrib>Mukumbwa-Mwenechanya, Mpande</creatorcontrib><creatorcontrib>Mulenga, Priscilla Lumano</creatorcontrib><creatorcontrib>Nichols, Brooke E</creatorcontrib><creatorcontrib>Rosen, Sydney</creatorcontrib><title>Attrition from HIV treatment after enrollment in a differentiated service delivery model: A cohort analysis of routine care in Zambia</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Many sub-Saharan Africa countries are scaling up differentiated service delivery (DSD) models for HIV treatment to increase access and remove barriers to care. We assessed factors associated with attrition after DSD model enrollment in Zambia, focusing on patient-level characteristics. We conducted a retrospective record review using electronic medical records (EMR) of adults (≥15 years) initiated on antiretroviral (ART) between 01 January 2018 and 30 November 2021. Attrition was defined as lost to follow-up (LTFU) or died by November 30, 2021. We categorized DSD models into eight groups: fast-track, adherence groups, community pick-up points, home ART delivery, extended facility hours, facility multi-month dispensing (MMD, 4-6-month ART dispensing), frequent refill care (facility 1-2 month dispensing), and conventional care (facility 3 month dispensing, reference group). We used Fine and Gray competing risk regression to assess patient-level factors associated with attrition, stratified by sex and rural/urban setting. Of 547,281 eligible patients, 68% (n = 372,409) enrolled in DSD models, most commonly facility MMD (n = 306,430, 82%), frequent refill care (n = 47,142, 13%), and fast track (n = 14,433, 4%), with &lt;2% enrolled in the other DSD groups. Retention was higher in nearly all DSD models for all dispensing intervals, compared to the reference group, except fast track for the ≤2 month dispensing group. Retention benefits were greatest for patients in the extended clinic hours group and least for fast track dispensing. Although retention in HIV treatment differed by DSD type, dispensing interval, and patient characteristics, nearly all DSD models out-performed conventional care. Understanding the factors that influence the retention of patients in DSD models could provide an important step towards improving DSD implementation.</description><subject>Adult</subject><subject>AIDS treatment</subject><subject>Analysis</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Anti-Retroviral Agents - therapeutic use</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral therapy</subject><subject>Antiviral agents</subject><subject>Biology and Life Sciences</subject><subject>Care and treatment</subject><subject>Clinical outcomes</subject><subject>Cohort analysis</subject><subject>Cohort Studies</subject><subject>Computer and Information Sciences</subject><subject>Datasets</subject><subject>Dispensing</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Electronic health records</subject><subject>Electronic medical records</subject><subject>Enrollments</subject><subject>Health risks</subject><subject>HIV</subject><subject>HIV (Viruses)</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - epidemiology</subject><subject>HIV patients</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Medical records</subject><subject>Medical research</subject><subject>Medicine and Health Sciences</subject><subject>Medicine, Experimental</subject><subject>Modelling</subject><subject>Patient satisfaction</subject><subject>Patients</subject><subject>People and Places</subject><subject>Retention</subject><subject>Retrospective Studies</subject><subject>Sexually transmitted diseases</subject><subject>STD</subject><subject>Urban areas</subject><subject>Urban environments</subject><subject>Zambia - epidemiology</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNk81uEzEQx1cIREvhDRBYQkJwSLDX--HlgqIKaKRKlfjogYs18Y4TR7vr1PZG5AF4b5xmW2VRD8gH2-Pf_Gc89iTJS0anjJfsw9r2roNmurEdTmkqaJmJR8kpq3g6KVLKHx-tT5Jn3q8pzbkoiqfJCS8qVuaFOE3-zEJwJhjbEe1sSy7m1yQ4hNBiFwjogI5g52zT3BpMR4DURmt0cWsgYE08uq1RSGpszBbdjrQ2Lj-SGVF2ZV1UiWnuvPHEauJsH0yHRIHDvdovaBcGnidPNDQeXwzzWfLzy-cf5xeTy6uv8_PZ5UQVFQ-TiuaMAq0yBSiYErpUFdM8T3OdIRc51hoKUeaqzqBK6zJTEVRVyXhBhWCUnyWvD7qbxno5VNDLtBRFWfKqyCMxPxC1hbXcONOC20kLRt4arFtKcMGoBmVGc0S-qGuqdVaBgpIBaMoBWXyKehG1Pg3R-kWLtYoVc9CMRMcnnVnJpd1KRinjQqRR4d2g4OxNjz7I1niFTQMd2v6QuGBpKrKIvvkHffh6A7WEeAPTaRsDq72onJUZS1le8H3Y6QNUHDW2RsX_pk20jxzejxwiE_B3WELvvZx___b_7NX1mH17xK4QmrDytun3_9WPwewAKme9d6jvq8yo3LfLXTXkvl3k0C7R7dXxC9073fUH_wtCZhGF</recordid><startdate>20230314</startdate><enddate>20230314</enddate><creator>Jo, Youngji</creator><creator>Jamieson, Lise</creator><creator>Phiri, Bevis</creator><creator>Grimsrud, Anna</creator><creator>Mwansa, Muya</creator><creator>Shakwelele, Hilda</creator><creator>Haimbe, Prudence</creator><creator>Mukumbwa-Mwenechanya, Mpande</creator><creator>Mulenga, Priscilla Lumano</creator><creator>Nichols, Brooke E</creator><creator>Rosen, Sydney</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-6560-2964</orcidid><orcidid>https://orcid.org/0000-0002-1199-8377</orcidid></search><sort><creationdate>20230314</creationdate><title>Attrition from HIV treatment after enrollment in a differentiated service delivery model: A cohort analysis of routine care in Zambia</title><author>Jo, Youngji ; Jamieson, Lise ; Phiri, Bevis ; Grimsrud, Anna ; Mwansa, Muya ; Shakwelele, Hilda ; Haimbe, Prudence ; Mukumbwa-Mwenechanya, Mpande ; Mulenga, Priscilla Lumano ; Nichols, Brooke E ; Rosen, Sydney</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c693t-90510a094cae81c8f7c91f3525f4e385edfa6875cd4a92d74ccaec97136088103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adult</topic><topic>AIDS treatment</topic><topic>Analysis</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Anti-Retroviral Agents - therapeutic use</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral therapy</topic><topic>Antiviral agents</topic><topic>Biology and Life Sciences</topic><topic>Care and treatment</topic><topic>Clinical outcomes</topic><topic>Cohort analysis</topic><topic>Cohort Studies</topic><topic>Computer and Information Sciences</topic><topic>Datasets</topic><topic>Dispensing</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Electronic health records</topic><topic>Electronic medical records</topic><topic>Enrollments</topic><topic>Health risks</topic><topic>HIV</topic><topic>HIV (Viruses)</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - epidemiology</topic><topic>HIV patients</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Medical records</topic><topic>Medical research</topic><topic>Medicine and Health Sciences</topic><topic>Medicine, Experimental</topic><topic>Modelling</topic><topic>Patient satisfaction</topic><topic>Patients</topic><topic>People and Places</topic><topic>Retention</topic><topic>Retrospective Studies</topic><topic>Sexually transmitted diseases</topic><topic>STD</topic><topic>Urban areas</topic><topic>Urban environments</topic><topic>Zambia - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jo, Youngji</creatorcontrib><creatorcontrib>Jamieson, Lise</creatorcontrib><creatorcontrib>Phiri, Bevis</creatorcontrib><creatorcontrib>Grimsrud, Anna</creatorcontrib><creatorcontrib>Mwansa, Muya</creatorcontrib><creatorcontrib>Shakwelele, Hilda</creatorcontrib><creatorcontrib>Haimbe, Prudence</creatorcontrib><creatorcontrib>Mukumbwa-Mwenechanya, Mpande</creatorcontrib><creatorcontrib>Mulenga, Priscilla Lumano</creatorcontrib><creatorcontrib>Nichols, Brooke E</creatorcontrib><creatorcontrib>Rosen, Sydney</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Agriculture Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jo, Youngji</au><au>Jamieson, Lise</au><au>Phiri, Bevis</au><au>Grimsrud, Anna</au><au>Mwansa, Muya</au><au>Shakwelele, Hilda</au><au>Haimbe, Prudence</au><au>Mukumbwa-Mwenechanya, Mpande</au><au>Mulenga, Priscilla Lumano</au><au>Nichols, Brooke E</au><au>Rosen, Sydney</au><au>Bartlett, Adam W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Attrition from HIV treatment after enrollment in a differentiated service delivery model: A cohort analysis of routine care in Zambia</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2023-03-14</date><risdate>2023</risdate><volume>18</volume><issue>3</issue><spage>e0280748</spage><epage>e0280748</epage><pages>e0280748-e0280748</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Many sub-Saharan Africa countries are scaling up differentiated service delivery (DSD) models for HIV treatment to increase access and remove barriers to care. We assessed factors associated with attrition after DSD model enrollment in Zambia, focusing on patient-level characteristics. We conducted a retrospective record review using electronic medical records (EMR) of adults (≥15 years) initiated on antiretroviral (ART) between 01 January 2018 and 30 November 2021. Attrition was defined as lost to follow-up (LTFU) or died by November 30, 2021. We categorized DSD models into eight groups: fast-track, adherence groups, community pick-up points, home ART delivery, extended facility hours, facility multi-month dispensing (MMD, 4-6-month ART dispensing), frequent refill care (facility 1-2 month dispensing), and conventional care (facility 3 month dispensing, reference group). We used Fine and Gray competing risk regression to assess patient-level factors associated with attrition, stratified by sex and rural/urban setting. Of 547,281 eligible patients, 68% (n = 372,409) enrolled in DSD models, most commonly facility MMD (n = 306,430, 82%), frequent refill care (n = 47,142, 13%), and fast track (n = 14,433, 4%), with &lt;2% enrolled in the other DSD groups. Retention was higher in nearly all DSD models for all dispensing intervals, compared to the reference group, except fast track for the ≤2 month dispensing group. Retention benefits were greatest for patients in the extended clinic hours group and least for fast track dispensing. Although retention in HIV treatment differed by DSD type, dispensing interval, and patient characteristics, nearly all DSD models out-performed conventional care. Understanding the factors that influence the retention of patients in DSD models could provide an important step towards improving DSD implementation.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>36917568</pmid><doi>10.1371/journal.pone.0280748</doi><tpages>e0280748</tpages><orcidid>https://orcid.org/0000-0002-6560-2964</orcidid><orcidid>https://orcid.org/0000-0002-1199-8377</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2023-03, Vol.18 (3), p.e0280748-e0280748
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2786773965
source Publicly Available Content Database; PubMed; Coronavirus Research Database
subjects Adult
AIDS treatment
Analysis
Anti-HIV Agents - therapeutic use
Anti-Retroviral Agents - therapeutic use
Antiretroviral agents
Antiretroviral drugs
Antiretroviral therapy
Antiviral agents
Biology and Life Sciences
Care and treatment
Clinical outcomes
Cohort analysis
Cohort Studies
Computer and Information Sciences
Datasets
Dispensing
Dosage and administration
Drug therapy
Electronic health records
Electronic medical records
Enrollments
Health risks
HIV
HIV (Viruses)
HIV Infections - drug therapy
HIV Infections - epidemiology
HIV patients
Human immunodeficiency virus
Humans
Medical records
Medical research
Medicine and Health Sciences
Medicine, Experimental
Modelling
Patient satisfaction
Patients
People and Places
Retention
Retrospective Studies
Sexually transmitted diseases
STD
Urban areas
Urban environments
Zambia - epidemiology
title Attrition from HIV treatment after enrollment in a differentiated service delivery model: A cohort analysis of routine care in Zambia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A35%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Attrition%20from%20HIV%20treatment%20after%20enrollment%20in%20a%20differentiated%20service%20delivery%20model:%20A%20cohort%20analysis%20of%20routine%20care%20in%20Zambia&rft.jtitle=PloS%20one&rft.au=Jo,%20Youngji&rft.date=2023-03-14&rft.volume=18&rft.issue=3&rft.spage=e0280748&rft.epage=e0280748&rft.pages=e0280748-e0280748&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0280748&rft_dat=%3Cgale_plos_%3EA741215632%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c693t-90510a094cae81c8f7c91f3525f4e385edfa6875cd4a92d74ccaec97136088103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2786773965&rft_id=info:pmid/36917568&rft_galeid=A741215632&rfr_iscdi=true